Michelia compressa-Derived Santamarine Inhibits Oral Cancer Cell Proliferation via Oxidative Stress-Mediated Apoptosis and DNA Damage

Hsin-I Lu,Kuan-Liang Chen,Ching-Yu Yen,Chung-Yi Chen,Tsu-Ming Chien,Chih-Wen Shu,Yu-Hsuan Chen,Jiiang-Huei Jeng,Bing-Hung Chen,Hsueh-Wei Chang

DOI: https://doi.org/10.3390/ph17020230

IF: 4.6

2024-02-10

Pharmaceuticals

Abstract:The anti-oral cancer effects of santamarine (SAMA), a Michelia compressa var. compressa-derived natural product, remain unclear. This study investigates the anticancer effects and acting mechanism of SAMA against oral cancer (OC-2 and HSC-3) in parallel with normal (Smulow–Glickman; S-G) cells. SAMA selectively inhibits oral cancer cell viability more than normal cells, reverted by the oxidative stress remover N-acetylcysteine (NAC). The evidence of oxidative stress generation, such as the induction of reactive oxygen species (ROS) and mitochondrial superoxide and the depletion of mitochondrial membrane potential and glutathione, further supports this ROS-dependent selective antiproliferation. SAMA arrests oral cancer cells at the G2/M phase. SAMA triggers apoptosis (annexin V) in oral cancer cells and activates caspases 3, 8, and 9. SAMA enhances two types of DNA damage in oral cancer cells, such as γH2AX and 8-hydroxy-2-deoxyguanosine. Moreover, all of these anticancer mechanisms of SAMA are more highly expressed in oral cancer cells than in normal cells in concentration and time course experiments. These above changes are attenuated by NAC, suggesting that SAMA exerts mechanisms of selective antiproliferation that depend on oxidative stress while maintaining minimal cytotoxicity to normal cells.

pharmacology & pharmacy,chemistry, medicinal

What problem does this paper attempt to address?

This paper aims to explore the inhibitory effect of Santamarine (SAMA), a natural product extracted from Michelia compressa, on the proliferation of oral cancer cells and its mechanism of action. Specifically, the research focuses on the following points:

1. **Selective inhibition of oral cancer cell proliferation**: The study found that SAMA can selectively inhibit the proliferation of oral cancer cells (OC - 2 and HSC - 3 cell lines), while having a relatively small impact on normal cells (such as the Smulow - Glickman cell line). This selective anti - proliferation effect can be reversed by the antioxidant N - acetylcysteine (NAC), indicating that the action of SAMA may depend on oxidative stress.

2. **Oxidative stress - mediated cell - cycle arrest**: SAMA can interfere with the cell cycle by inducing oxidative stress, especially arresting oral cancer cells in the G2/M phase. This further supports the hypothesis that SAMA exerts its anti - proliferation effect through the oxidative stress pathway.

3. **Induction of apoptosis and DNA damage**: SAMA can induce apoptosis in oral cancer cells and activate apoptosis - related proteins such as caspase 3, 8, and 9. In addition, SAMA can also enhance the expression of two types of DNA damage markers, γH2AX and 8 - hydroxy - 2' - deoxyguanosine (8 - OHdG). These effects can also be inhibited by NAC, further demonstrating that the mechanism of action of SAMA is closely related to oxidative stress.

4. **Safety assessment**: Research shows that SAMA has relatively low toxicity to normal cells, suggesting that it may be a potentially safe and effective anti - cancer drug.

In conclusion, this study reveals that SAMA selectively inhibits the proliferation of oral cancer cells through an oxidative stress - mediated mechanism and induces apoptosis and DNA damage. This finding provides an important scientific basis for the development of new anti - cancer drugs.